Houston co. unveils Prada-designed spacesuit to be used on the moon

from catwalk to moonwalk

Axiom says the suit, which fits men and women, will enable astronauts to perform a spacewalk for at least eight hours. Photo courtesy of Axiom Space

Fashion met the future this week as Houston-based Axiom Space and the Prada apparel brand revealed the design of the spacesuit that NASA astronauts will wear during their upcoming journey to the moon.

Axiom, a space exploration company, and Prada, a fixture in the world of luxury fashion, debuted their design of the Axiom Extravehicular Mobility Unit (AxEMU) spacesuit at the International Astronautical Congress in Milan, Italy.

Set for 2026, NASA’s Artemis III mission will be the first “staffed” lunar landing since Apollo 17 in 1972. Four astronauts have been selected for the 30-day mission.

Components of the white, gray, and red spacesuit include:

  • Lights
  • HD camera
  • Cellular communications
  • “Endurance athlete”-style nutrition
  • Backpack with portable life support system
  • Custom-made gloves
  • Boots designed to withstand lunar temperatures and rough terrain

The spacesuit work is being performed under a nearly $1.3 billion NASA contract. Photo courtesy of Axiom Space

Axiom says the suit, which fits men and women, will enable astronauts to perform a spacewalk for at least eight hours. It’s geared toward lunar missions and low-earth-orbit missions.

“The AxEMU has significant advancements in safety, mobility, sizing, and performance,” the company says.

During development of the suit, Axiom placed a dark cover on the outer layer to conceal the suit’s proprietary technology. However, the suits worn on the lunar surface will be made from a white material that reflects heat, and protects astronauts from extreme high temperatures and lunar dust.

The spacesuit work is being performed under a nearly $1.3 billion NASA contract.

“Going beyond our limits is one of the company’s values that perfectly reflects the spirit of the Prada brand and my parents’ vision. I’m very proud of the result we’re showing today, which is just the first step in a long-term collaboration with Axiom Space,” Lorenzo Bertelli, Prada’s chief marketing officer and head of corporate social responsibility, says in a news release.

Axiom says the suit is near the final stage of development. Already, it has gone through testing by astronauts and engineers at Axiom, NASA, and SpaceX facilities. Among the tests were reduced-gravity simulations at NASA’s Johnson Space Center in Houston and underwater simulations at NASA’s Neutral Buoyancy Laboratory, also in Houston.

The suit will undergo an in-depth design review in 2025.

From Your Site Articles
Prada is collaborating with Houston-based aerospace company Axiom Space on the design of spacesuits for NASA’s Artemis III mission to the moon. Photo via axiomspace.com

Houston company collaborates with major fashion designer for spacesuit project

astronaut couture

Courtesy of the Prada luxury brand, NASA astronauts are getting an infusion of fashion.

Prada is collaborating with Houston-based aerospace company Axiom Space on the design of spacesuits for NASA’s Artemis III mission to the moon. Astronauts haven’t yet been chosen for the mission, which is set for 2025.

“Prada’s technical expertise with raw materials, manufacturing techniques, and innovative design concepts will bring advanced technologies instrumental in ensuring not only the comfort of astronauts on the lunar surface, but also the much-needed human factors considerations absent from legacy spacesuits,” says Michael Suffredini, co-founder, president, and CEO of Axiom Space.

The spacesuit, called the Axiom Extravehicular Mobility Unit (AxEMU), is geared toward improving astronauts’ flexibility, boosting protection against harsh conditions, and supplying tools for exploration and scientific activities.

“Our decades of experimentation, cutting-edge technology, and design know-how – which started back in the ’90s with Luna Rossa challenging for the America’s Cup – will now be applied to the design of a spacesuit for the Artemis era. It is a true celebration of the power of human creativity and innovation to advance civilization,” says Lorenzo Bertelli, marketing director of the Prada brand.

NASA has enlisted Axiom and Charlotte, North Carolina-based Collins Aerospace to outfit astronauts with next-generation spacesuits. Axiom’s partners on this project are KBR and Sophic Synergistics, both based in Houston, along with Air-Lock, A-P-T Research, Arrow Science and Technology, David Clark Co., and Paragon Space Development.

Collins maintains a sizable presence at the Houston Spaceport.

In July, Axiom secured a NASA task order potentially worth $147 million to modify the Artemis III spacesuit for astronauts heading to the International Space Station. This follows a $228 million NASA task order awarded to Axiom in 2022 for development of the Artemis III spacesuit.

The task orders are part of Axiom’s $1.26 billion spacesuit contract with NASA. All told, NASA has earmarked as much as $3.5 billion for new spacesuits.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Meta to bring $115 million AI data center training initiative to Houston

ai workforce

Meta and Associated Builders and Contractors have entered into a partnership to invest $115 million in training programs for the construction of AI data centers, with a portion of the project launching in Houston.

The companies announced June 8 that they would open America’s Workforce Academies at ABC chapter training centers in Houston; Indianapolis; Baton Rouge, Louisiana; and Columbus, Ohio.

The academies will offer career readiness and safety training, plus five weeks of hands-on education. Participants who complete the program will be granted a job offer from contractors working on Meta projects.

“The AI revolution is bringing change but also historic opportunities,” Dina Powell McCormick, Meta president and vice-chairman, said in a news release. “Skilled workers electrified rural America one pole at a time. They manned the factories that built the arsenal that won World War II. Now a new generation will pour the foundations and lay the fiber that secures American strength in this new age.”

Overall, the Meta and ABC aim for the academies to build a more sustainable pipeline of skilled construction workers and ensure safety and job readiness for the surging number of data center projects underway.

“This new program is an innovative talent solution that is a critical part of addressing the construction industry’s ongoing workforce shortage and creates an accelerated, new-entrant strategy for job seekers ... The sustained demand for data center construction technicians means the industry needs an all-of-the-above approach to address this shortage and grow the construction talent pool,” Michael Bellaman, ABC president and CEO, added in the release.

In Texas, Meta, the parent company of Facebook and Instagram, has launched or broken ground on data centers in El Paso, Fort Worth and Temple. The company announced in March that it planned to grow its El Paso Data center by 1 gigawatt, representing more than a $10 billion investment.

Apart from Meta, Texas has attracted data center development to power other giants like Google and Amazon in recent years. In turn, Texas has been predicted to become the biggest data center market. Commercial real estate services provider JLL reported this spring that the state could topple Northern Virginia as the world’s largest data-center market by 2030. Similarly, CBRE predicted that Houston's data center capacity could double by 2028. Read more here.

New Houston biotech co. lands $30M for pulmonary fibrosis drug

drug money

Most of us can claim a scar or two on our bodies. But when scarring develops inside the body, it’s known as a fibrotic disorder. A freshly launched Houston company, Oorja Bio Inc., is working on a treatment that can help to repair cells and reduce the damage wrought by the growth of fibrotic tissue in patients.

Late last month, Oorja Bio hit the scene with a pair of big announcements. Not only has the company raised a $30 million Series A thanks to founding investor California-based Westlake BioPartners, but it has also already paved the way for a Phase 2 study to take place this year.

Oorja Bio received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA), allowing the company to test its treatment in patients with idiopathic pulmonary fibrosis (IPF), a scarring of the lung tissue. IPF affects more than 150,000 adults in the United States and can result in a range of symptoms from shortness of breath to organ failure and death as it progresses.

Oorja Bio’s lead drug candidate, ORJ-001, was shown in a Phase 1 in-human trial to demonstrate “therapeutically relevant exposure and favorable tolerability” in 64 healthy adult volunteers in whom it was administered daily or weekly, according to a news release. Pre-clinical studies of ORJ-001 showed durable target tissue engagement and biomarker activity in bleomycin-induced lung fibrosis.

Administered subcutaneously, ORJ-001 is intended to improve and even restore function in cells that can reduce the signaling that causes IPF. It stops advancement of IPF and also allows for tissue repair. Currently available treatments for the disease can slow the development of IPF down, but do not address the declining lung function that’s inherent in its progression.

“The clinical and preclinical results from our studies to date give us confidence that ORJ-001 represents a novel treatment approach with the potential to repair and reverse fibrosis and modify disease progression in IPF,” Dr. Janethe Pena, CMO of Oorja Bio, said in the release.

“Our team is energized to deliver on our goal of redefining the future of fibrotic diseases, beginning with ORJ-001,” CEO and founder Sujay Kango added. “As we advance ORJ-001 in the clinic, we are embracing the paradigm shift in our biological understanding of IPF pathology that aligns with the central role of the alveolar epithelium. ORJ-001 was designed with this biology in mind and may provide, for the first time, a therapeutic intervention that repairs and reverses fibrosis and promotes disease modification.”

Most patients live only three to five years following their IPF diagnosis. Soon, ORJ-001 and Oorja Bio could give them a fighting chance.

Axiom Space tops $525M in oversubscribed round, announces Swiss subsidiary

funding boost

Axiom Space tacked on an additional $175 million to a previously announced capital raise, bringing the oversubscribed round to a total of more than $525 million.

Axiom shared in February that it had secured $350 million in a financing round led by Type One Ventures and Qatar Investment Authority. In the latest release from the company, Axiom reports that Japan-based MUFG Bank Ltd. joined the round as a new investor, in addition to continued participation from existing backers.

The funding will go toward developing the company's commercial space station, known as Axiom Station, and the production of its Axiom Extravehicular Mobility Unit (AxEMU) under its NASA spacesuit contract.

“Investor interest in this round outpaced what we set out to raise, which speaks to the moment we’re in,” Jonathan Cirtain, CEO and president of Axiom Space, said in the news release. “Our partners see what is possible in low-Earth orbit, and they see who is positioned to lead it.”

Axiom announced last month that it planned to open a Japanese subsidiary July 1. Earlier this week, it also shared plans to establish Axiom Space Switzerland, a wholly owned subsidiary based in Lucerne that is also expected to begin operations this summer.

The Switzerland subsidiary aims to establish Axiom's presence in Europe and help it partner with the European Space Agency and other space organizations and companies on the continent.

“Europe is a founding leader in the creation of the commercial space economy, and Switzerland is uniquely positioned to convene the government agencies, research institutions, and industrial entities that will shape its next decade,” Cirtain added in a separate release. “Axiom Space Switzerland facilitates the scaling of development and deployment of the infrastructure that will succeed the International Space Station.”

View All Listings